ACAD ACADIA Pharmaceuticals Inc.

27.55
-0.46  -2%
Previous Close 28.01
Open 28.09
Price To book 7.47
Market Cap 3.36B
Shares 122,046,000
Volume 1,220,181
Short Ratio 10.10
Av. Daily Volume 1,636,010

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 initiated November 2016.
Pimavanserin
Adjunctive treatment in patients with negative symptoms of schizophrenia
Phase 3 initiated November 2016.
Pimavanserin
Adjunctive treatment of schizophrenia
Phase 2 trial initiated October 2016.
Pimavanserin - SERENE
Alzheimer’s disease agitation
Approved April 29 2016
Pimavanserin
Parkinson’s disease psychosis (PDP)
Phase 2 top-line data released December 20, 2016. Primary endpoint met. Key secondary endpoint missed. Phase 3 trial to be initiated 2H 2017.
Pimavanserin
Alzheimer’s disease psychosis

Latest News

  1. Edited Transcript of ACAD earnings conference call or presentation 9-May-17 9:00pm GMT
  2. The Acadia Sell-off Is Overdone
  3. Is This Why Acadia Pharmaceuticals Inc. Is Plunging Today?
  4. Acadia reports 1Q loss
  5. ACADIA Pharmaceuticals Reports First Quarter 2017 Financial Results
  6. Investor Network: ACADIA Pharmaceuticals Inc. to Host Earnings Call
  7. ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference on May 16, 2017
  8. What to do when your biotechnology stock gets hit by takeover rumors
  9. What's in the Cards for ACADIA (ACAD) this Earnings Season?
  10. ACADIA Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 9, 2017
  11. ETFs with exposure to ACADIA Pharmaceuticals, Inc. : May 1, 2017
  12. Acadia Pharmaceuticals May Just Be the Best Long-Term Play on the Alzheimer's Disease Treatment Market
  13. Biotech M&A Plunges as Trump Attacks Drug Companies
  14. ETFs with exposure to ACADIA Pharmaceuticals, Inc. : April 19, 2017
  15. What Does Big Pharma Want To Buy? 3 Drugmakers On Merger Track
  16. ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial Officer
  17. ACADIA Pharmaceuticals to Present at Needham & Company’s 16th Annual Healthcare Conference on April 5, 2017
  18. 3 Top Biotech Stocks to Buy in 2017
  19. Blog Coverage Egalet Receives New US and International Patents for Guardian(TM) Technology